Abstract
GLI gene-mediated hedgehog (Hh) signaling pathway plays a substantial role in brain cancer development and growth including glioblastoma multiforme (GBM), lower-grade glioma (LGG), and medulloblastoma (MB). GLI2 and GLI3 gene expression levels are extremely enhanced in these cancers with poor patient survival. Moreover, GLI genes are correlated with stemness-related factors SOX2, SOX9, POU5F1, and NANOG that work as the driving factors for brain cancer stem cells (CSCs) progression. It's critical to find new ways to combat this deadly malignancy and CSCs. Using in silico approaches, our study explored the role of GLI genes (GLI1, GLI2, and GLI3), the primary transcription factors of the sonic hedgehog (SHH) signaling pathway, in GBM, LGG, MB, and glioblastoma stem-like cells (GSCs). Additionally, we found strong association of angiogenic-related gene VEGFA, metabolic genes ENO1, ENO2, and pluripotency-related genes SOX2, SOX9, NANOG, POU5F1 with GLI genes, suggesting their role in brain tumor initiation and progression. We also studied their transcriptional network and functional category enrichment analysis about brain tumor development to find a better therapeutic strategy against brain cancer and their stem cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
All the data related to this study will be made available on request for further study and analysis.
References
Anjum K, Shagufta BI, Abbas SQ, Patel S, Khan I, Shah SAA, Akhter N, Hassan SS, ul, (2017) Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review. Biomed Pharmacother 92:681–689. https://doi.org/10.1016/j.biopha.2017.05.125
Arceci RJ (2008) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Yearb Oncol 2008:286–287. https://doi.org/10.1016/s1040-1741(08)79162-0
Arheden K, Rønne M, Mandahl N, Heim S, Kinzler KW, Vogelstein B, Mitelman F (1989) In situ hybridization localizes the human putative oncogene GLI to chromosome subbands 12q13.3–14.1. Hum Genet 82(1):1–2. https://doi.org/10.1007/BF00288260
Beck B, Blanpain C (2013) Unravelling cancer stem cell potential. Nat Rev Cancer 13(10):727–738. https://doi.org/10.1038/nrc3597
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401–410. https://doi.org/10.1038/nrc1093
Bermudez O, Hennen E, Koch I, Lindner M, Eickelberg O (2013) Gli1 mediates lung cancer cell proliferation and sonic hedgehog-dependent Mesenchymal cell activation. PLoS ONE. https://doi.org/10.1371/journal.pone.0063226
Bora-Singhal N, Perumal D, Nguyen J, Chellappan S (2015) Gli1-mediated regulation of Sox2 facilitates self-renewal of stem-like cells and confers resistance to EGFR Inhibitors in non-small cell lung cancer. Neoplasia (United States) 17(7):538–551. https://doi.org/10.1016/j.neo.2015.07.001
Bostwick DG, Meiers I (2009) Prostate. Mod Surg Pathol 2:1121–1180. https://doi.org/10.1016/B978-1-4160-3966-2.00032-1
Carpenter RL, Paw I, Zhu H, Sirkisoon S, Xing F, Watabe K, Debinski W, Lo HW (2015) The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis. Oncotarget 6(26):22653–22665. https://doi.org/10.18632/oncotarget.4248
Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, Phillips HS (2010) A Hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17(4):362–375. https://doi.org/10.1016/j.ccr.2009.12.049
Fan Q, He M, Sheng T, Zhang X, Sinha M, Luxon B, Zhao X, Xie J (2010) Requirement of TGF β signaling for SMO-mediated carcinogenesis. J Biol Chem 285(47):36570–36576. https://doi.org/10.1074/jbc.C110.164442
Gricius D, Kazlauskas A (2014) Analysis of oncogene GLI1 protein expression levels between differing grades of astrocytoma. Biologija. https://doi.org/10.6001/biologija.v60i3.2973
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J (2010) Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 16(8):2443–2449. https://doi.org/10.1158/1078-0432.CCR-09-3106
Hatton BA, Knoepfler PS, Kenney AM, Rowitch DH, Moreno De Alborán I, Olson JM, Eisenman RN (2006) N-myc is an essential downstream effector of shh signaling during both normal and neoplastic cerebellar growth. Cancer Res 66(17):8655–8661. https://doi.org/10.1158/0008-5472.CAN-06-1621
Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neuro-Oncol 104(3):639–646. https://doi.org/10.1007/s11060-011-0565-x
Ji M, Wang Z, Chen J, Gu L, Chen M, Ding Y, Liu T (2019) Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin. Biosci Rep. https://doi.org/10.1042/BSR20190503
Justilien V, Fields AP (2015) Molecular pathways: novel approaches for improved therapeutic targeting of hedgehog signaling in cancer stem cells. Clin Cancer Res 21(3):505–513. https://doi.org/10.1158/1078-0432.CCR-14-0507
Kar S, Deb M, Sengupta D, Shilpi A, Bhutia SK, Patra SK (2012) Intricacies of hedgehog signaling pathways: a perspective in tumorigenesis. Exp Cell Res 318(16):1959–1972. https://doi.org/10.1016/j.yexcr.2012.05.015
Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O’Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science (80-) 236(4797):70–73. https://doi.org/10.1126/science.3563490
Kinzler KW, Ruppert JM, Bigner SH, Vogelstein B (1988) The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature 332(6162):371–374. https://doi.org/10.1038/332371a0
Kool M, Korshunov A, Remke M, Jones DTW, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-Van Meeteren A, Van Vuurden D, Clifford SC, Pietsch T, Von Bueren AO, Rutkowski S, McCabe M, Collins VP, Bäcklund ML, Haberler C, Bourdeaut F, Pfister SM (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123(4):473–484. https://doi.org/10.1007/s00401-012-0958-8
Lee JH, Liu R, Li J, Zhang C, Wang Y, Cai Q, Qian X, Xia Y, Zheng Y, Piao Y, Chen Q, De Groot JF, Jiang T, Lu Z (2017) Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nat Commun. https://doi.org/10.1038/s41467-017-00906-9
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Manoranjan B, Wang X, Hallett RM, Venugopal C, Mack SC, McFarlane N, Nolte SM, Scheinemann K, Gunnarsson T, Hassell JA, Taylor MD, Lee C, Triscott J, Foster CM, Dunham C, Hawkins C, Dunn SE, Singh SK (2013) Foxg1 interacts with bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells. Stem Cells 31(7):1266–1277. https://doi.org/10.1002/stem.1401
Northcott PA, Shih DJH, Peacock J, Garzia L, Sorana Morrissy A, Zichner T, Stútz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, MacK S, Dubuc A, Yao Y, Ramaswamy V, Luu B, Taylor MD (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 487(7409):49–56. https://doi.org/10.1038/nature11327
Ooki A, Dinalankara W, Marchionni L, Tsay JCJ, Goparaju C, Maleki Z, Rom WN, Pass HI, Hoque MO (2018) Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Oncogene 37(45):5967–5981. https://doi.org/10.1038/s41388-018-0373-2
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22(Supplement_1):IV1–IV96. https://doi.org/10.1093/neuonc/noaa200
Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D, Casanovas O (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15(3):220–231. https://doi.org/10.1016/j.ccr.2009.01.027
Pola R, Ling LE, Silver M, Corbley MJ, Kearney M, Blake Pepinsky R, Shapiro R, Taylor FR, Baker DP, Asahara T, Isner JM (2001) The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med 7(6):706–711. https://doi.org/10.1038/89083
Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, Shih DJ, Luu B, Dubuc AM, Northcott PA, Schüller U, Gururangan S, McLendon R, Bigner D, Fouladi M, Ligon KL, Pomeroy SL, Dunn S, Triscott J, Taylor MD (2013) Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol 14(12):1200–1207. https://doi.org/10.1016/S1470-2045(13)70449-2
Ranjan A, Srivastava SK (2017) Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1. Oncotarget 8(20):32960–32976. https://doi.org/10.18632/oncotarget.16515
Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C, Frischauf AM, Aberger F (2004) Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 64(21):7724–7731. https://doi.org/10.1158/0008-5472.CAN-04-1085
Sabol M, Trnski D, Musani V, Ozretić P, Levanat S (2018) Role of GLI transcription factors in pathogenesis and their potential as new therapeutic targets. Int J Mol Sci. https://doi.org/10.3390/ijms19092562
Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61(18):6674–6678
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Suvà ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, Beik S, Kadri S, Tirosh I, Wortman I, Bernstein BE (2014) Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157(3):580–594. https://doi.org/10.1016/j.cell.2014.02.030
Tabatabai G, Weller M (2011) Glioblastoma stem cells. Cell Tissue Res 343(3):459–465. https://doi.org/10.1007/s00441-010-1123-0
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872. https://doi.org/10.1016/j.cell.2007.11.019
Tanigawa S, Fujita M, Moyama C, Ando S, Ii H, Kojima Y, Fujishita T, Aoki M, Takeuchi H, Yamanaka T, Takahashi Y, Hashimoto N, Nakata S (2021) Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model. Cancer Gene Ther. https://doi.org/10.1038/s41417-020-00282-5
Vizin T, Kos J (2015) Gamma-enolase: a well-known tumour marker, with a less-known role in cancer. Radiol Oncol 49(3):217–226. https://doi.org/10.1515/raon-2015-0035
Wang H, Wang H, Zhang W, Huang HJ, Liao WSL, Fuller GN (2004) Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas. Lab Investig 84(8):941–951. https://doi.org/10.1038/labinvest.3700123
Wang K, Chen D, Qian Z, Cui D, Gao L, Lou M (2017) Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma. Cancer Cell Int. https://doi.org/10.1186/s12935-017-0491-x
Weathers SP, Gilbert MR (2014) Advances in treating glioblastoma. F1000Prime Rep. https://doi.org/10.12703/P6-46
Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ (2006) The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Int J Cancer 119(7):1519–1529. https://doi.org/10.1002/ijc.21865
Xu L, Lina W, Xuejun Y (2016) The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer. Open Med 11(1):59–62. https://doi.org/10.1515/med-2016-0012
Young RM, Jamshidi A, Davis G, Sherman JH (2015) Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med. https://doi.org/10.3978/j.issn.2305-5839.2015.05.10
Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz I, Altaba A (2010) NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 29(15):2659–2674. https://doi.org/10.1038/emboj.2010.137
Zhan P, Wang Y, Zhao S, Liu C, Wang Y, Wen M, Mao JH, Wei G, Zhang P (2015) FBXW7 negatively regulates ENO1 expression and function in colorectal cancer. Lab Investig 95(9):995–1004. https://doi.org/10.1038/labinvest.2015.71
Zhang B, Gu F, She C, Guo H, Li W, Niu R, Fu L, Zhang N, Ma Y (2009) Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125(3):585–595. https://doi.org/10.1002/ijc.24314
Acknowledgements
The authors are thankful to the laboratory colleagues and School of Health Sciences and Technology (SoHST), UPES University, Dehradun, Uttarakhand, 248007, India for partial financial support for this study. We thank our lab members and collaborators for carefully reading the manuscript and contributing valuable inputs for improving the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that there are no conflicts of interests among the authors about the publication of the manuscript.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Agrawal, K., Chauhan, S. & Kumar, D. Expression analysis and regulation of GLI and its correlation with stemness and metabolic alteration in human brain tumor. 3 Biotech 13, 10 (2023). https://doi.org/10.1007/s13205-022-03419-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-022-03419-5